William R. Kelly Ph.D. on September 26, 2018
U.S. drug policy is ineffective, counterproductive, and expensive. The evidence indicates an effective and efficient path forward by reducing demand.
U.S. drug policy is ineffective, counterproductive, and expensive. The evidence indicates an effective and efficient path forward by reducing demand.